The anabolic effects of GIP may play a physiologically permissive role for adipose tissue synthesis, and GIP antagonist antibodies have been developed as pharmacological agents for obesity treatment (68, 74) (Figure 1 – Section E). The gene discussed is GIP; the disease is Obesity.